---
schema_version: "secwatch.filing_event.v1"
accession: "0001906324-24-000048"
form_type: "8-K"
ticker: "QDEL"
cik: "0001906324"
company_name: "QuidelOrtho Corp"
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:56:01.627716+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# QuidelOrtho Q3 GAAP net loss $20M ($0.30 EPS); revenue $727M; reinstates 2024 guidance

## Summary
- Revenue $727M vs $744M YoY; Labs revenue grew 4% as reported (5% constant currency).
- GAAP net loss $20M ($0.30 diluted EPS) vs loss $13M ($0.19) prior year; GAAP operating margin 2%.
- Adjusted EBITDA margin 23.5%, up 80 bps; GAAP operating expenses down $13M to $242M.
- Company reinstated 2024 financial guidance after withdrawing prior outlook.
- Integration-related charges of $37M; new CTO and CHRO appointed.

## SEC filing metadata
- accession: 0001906324-24-000048
- form_type: 8-K
- ticker: QDEL
- cik: 0001906324
- company_name: QuidelOrtho Corp
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000048/0001906324-24-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000048/qdel-20241107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001906324-24-000048
- JSON: https://secwatch.observer/filing/0001906324-24-000048.json
- Plain text: https://secwatch.observer/filing/0001906324-24-000048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.